Position in HLN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$98,375
-$16,880 QoQ
Shares Held
10,544
-8.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#391
of 639 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Perigon Wealth Management, LLC holds $2,424,384 across 8 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HROW |
Harrow, Inc.
|
13,229 | $561,835 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
15,717 | $544,908 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
3,524 | $390,952 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
594 | $321,847 | |
| 5 | VTRS |
Viatris Inc
|
16,003 | $254,127 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
16,628 | $240,939 | |
| 7 | HLN |
Haleon plc
This page
|
10,544 | $98,375 | |
| 8 | ADCT |
ADC Therapeutics SA
|
10,656 | $11,401 |
All Filings in HLN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,375 | 10,544 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $115,255 | 11,514 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $107,691 | 10,652 | Shares | Sole | 2026-01-16 | |
| 2024-03-31 | $112,246 | 13,221 | Shares | Sole | 2024-04-29 | |
| 2023-09-30 | $89,764 | 10,776 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $97,115 | 11,589 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $93,642 | 11,504 | Shares | Sole | 2023-05-03 | |
| No filing history on record for this holder in this stock. | ||||||